Crinetics Pharmaceuticals Inc. (CRNX)
Market Closed
17 Jul, 20:00
$
83. 86
-0.05
-0.0596%
$
8.88B Market Cap
- P/E Ratio
- Div Yield
5.37M Volume
-3.64 Eps
$ 83.91
Previous Close 
Want to track CRNX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Crinetics Pharmaceuticals Inc. (CRNX) Statistics
Valuation metrics
Market Cap 8.88B
Enterprise value 8.81B
Trailing P/E (ttm) -16.32
Forward P/E -8.81
PEG ratio 0.59
Price/Sales (ttm) 491.21
Price/Book (mrq) 6.82
Enterprise Value/Revenue 487.53
Enterprise Value/EBITDA -17.9
Overview
Shares outstanding 95.58M
Float 96.99M
Shares short 14.17M
% Held by insiders 0.02%
% Held by institutions 1.11%
Average volume (10 days) 4.54M
Average volume (90 days) 1.59M
Price summary
52-Week low 25.83
52-Week high 84
Beta 0.28
50-Day moving average 41.22
200-Day moving average 42.32
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -27.47%
Operating margin -30.2%
Operational effectiveness
Return on assets -0.35%
Return on equity -0.44%
Income Statement
Revenue (ttm) 18.07M
Revenue per share (ttm) 0.17
Quarterly revenue growth (yoy) 28.73%
Gross profit (ttm) -339.11M
EBITDA -541.62M
Net income to common (ttm) -496.39M
Diluted EPS (ttm) -4.77
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.29B
Total cash per share (mrq) 12.4
Total debt (mrq) 47.85M
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 18.6%
Book value per share (mrq) 12.3
Cash Flow
Cash flow statement -414.17M
Levered free cash flow (LFCF) -242.14M
